Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Glossitis, Hypogeusia, Papule, Tongue discolouration
Clinical narrative: A raised painful red papule surrounded by inflamed purple tissue on the dorsal surface of the tongue anteriorly along with greatly diminished taste; a raised painful red papule surrounded by inflamed purple tissue on the dorsal surface of the tongue anteriorly along with greatly diminished taste; a raised painful red papule surrounded by inflamed purple tissue on the dorsal surface of the tongue anteriorly along with greatly diminished taste; a raised painful red papule surrounded by inflamed purple tissue on the dorsal surface of the tongue anteriorly along with greatly diminished taste; This is a spontaneous report from a contactable physician. A 76-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9265), intramuscularly, administered in Arm Right on 05Feb2021 at 12:00 (at the age of 76-year-old at vaccination) as a Dose 2, single for COVID-19 immunization. The patient was non-pregnant during vaccination. The patient' medical history included ablation for atrial fibrillation (AFib) from Mar2020, Hypertension, Hypothyroidism, Lymphoedema, Anaphylactic reactions to mango, pistachio, shellfish, glossitis and Glossitis to Sulfa drugs and the patient was inserted with Dual-chamber pacemaker May2021 for 3rd degree heart block. The patient' concomitant medication(s) included cyanocobalamin [B12], bioflavonoids NOS, lecithin, quercetin, ubidecarenone (CO-Q-10 PLUS), colecalciferol (D3), diltiazem, disopyramide, azilsartan kamedoxomil (EDARBI), furosemide (LASIX), levothyroxine sodium (SYNTHROID), hydrochlorothiazide, triamterene (TRIAMTERENE/HCTZ), rivaroxaban (XARELTO) within two weeks covid-19 vaccination. The patient's past medications included levofloxacin (LOVENOX) and Arixtra. The patient had bleeding and swelling because of Lovenox and Arixtra use and allergic to both the drugs. Vaccination facility type was reported as Clinic. The patient was not infected with Covid prior vaccination. The patient was not on any other vaccine in four weeks prior to Covid-19 vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3248) via unspecified route, administered in Arm Right on 11Jan2021 at 15:30 (at the age of 76-year-old at vaccination) as a Dose 1, single for COVID-19 immunization. On 07Feb2021 at 08:30 PM, the patient had a raised painful red papule surrounded by inflamed purple tissue on the dorsal surface of the tongue anteriorly along with greatly diminished taste. Symptoms started about 55-60 hours after 2nd Covid-19 vaccine injection. Both papule and diminished taste are present and unchanged 72 hours after vaccination. The AE resulted the patient to visit Doctor or other healthcare professional office/clinic visit. The patient was not covid tested post vaccination. The patient had not received any treatment medications for the resulted events. The outcome of the events was not recovered. Follow-up attempts completed. No further information expected.